Experienced in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy

Dr. Craig M. Walker

Interventional Cardiology | Cardiology
191 Innovation Ct., Suite A, 
Gray, LA 
Accepting New Patients
Offers Telehealth
Experienced in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
191 Innovation Ct., Suite A, 
Gray, LA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Craig Walker is an Interventional Cardiologist and a Cardiologist in Gray, Louisiana. Dr. Walker is rated as an Experienced provider by MediFind in the treatment of Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy. His top areas of expertise are Venous Insufficiency, Stasis Dermatitis and Ulcers, Peripheral Artery Disease, Atherosclerosis, and Angioplasty. Dr. Walker is currently accepting new patients.

His clinical research consists of co-authoring 12 peer reviewed articles and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Interventional Cardiology
Cardiology
Licenses
Internal Medicine in LA
Hospital Affiliations
Terrebonne General Medical Center - Parish
Ochsner Lafayette General Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Louisiana Healthcare Connections
  • HMO
  • MANAGED MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Cardiovascular Institute
191 Innovation Ct., Suite A, Gray, LA 70359

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

A Clinical Evaluation of the MicroSTent® PeripherAl Vascular SteNt in Subjects With Arterial Disease Below the Knee (STAND)
A Clinical Evaluation of the MicroSTent® PeripherAl Vascular SteNt in Subjects With Arterial Disease Below the Knee (STAND)
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Device
Study Phase: Not Applicable
LIFE-BTK (pivotaL Investigation of saFety and Efficacy of BRS Treatment-Below The Knee) Randomized Controlled Trial
LIFE-BTK (pivotaL Investigation of saFety and Efficacy of BRS Treatment-Below The Knee) Randomized Controlled Trial
Enrollment Status: Active_not_recruiting
Publish Date: May 30, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Randomized Trial Comparing the Drug-Eluting Stent (DES) Below-the-Knee (BTK) Vascular Stent System (DES BTK Vascular Stent System) vs Percutaneous Transluminal Angioplasty (PTA) Treating Infrapopliteal Lesions in Subjects With Critical Limb Ischemia
A Randomized Trial Comparing the Drug-Eluting Stent (DES) Below-the-Knee (BTK) Vascular Stent System (DES BTK Vascular Stent System) vs Percutaneous Transluminal Angioplasty (PTA) Treating Infrapopliteal Lesions in Subjects With Critical Limb Ischemia
Enrollment Status: Completed
Publish Date: July 01, 2024
Intervention Type: Combination product, Device
Study Phase: Phase 3
A Prospective, Multi-Center, Single-Arm, Real-World Study Assessing the Clinical Use of the Bard® UltraScore™ Focused Force PTA Balloon
A Prospective, Multi-Center, Single-Arm, Real-World Study Assessing the Clinical Use of the Bard® UltraScore™ Focused Force PTA Balloon
Enrollment Status: Completed
Publish Date: March 28, 2024
Intervention Type: Device
A Randomized Trial to Confirm the Safety and Effectiveness of Chocolate Touch™ Paclitaxel Coated Balloon Catheter, in Above the Knee Lesions
A Randomized Trial to Confirm the Safety and Effectiveness of Chocolate Touch™ Paclitaxel Coated Balloon Catheter, in Above the Knee Lesions
Enrollment Status: Active_not_recruiting
Publish Date: October 30, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Prospective, Multicentre Observational Study to Evaluate the BioMimics 3D Vascular Stent System in the Treatment of Peripheral Arterial Disease: MIMICS-3D-USA
A Prospective, Multicentre Observational Study to Evaluate the BioMimics 3D Vascular Stent System in the Treatment of Peripheral Arterial Disease: MIMICS-3D-USA
Enrollment Status: Unknown
Publish Date: November 16, 2022
Intervention Type: Device
Evaluation of the Cardio Flow FreedomFlow™ Orbital Circumferential Atherectomy System to Treat Peripheral Artery Disease
Evaluation of the Cardio Flow FreedomFlow™ Orbital Circumferential Atherectomy System to Treat Peripheral Artery Disease
Enrollment Status: Completed
Publish Date: November 04, 2022
Intervention Type: Device
Study Phase: Not Applicable
Natural Vascular Scaffolding (NVS) Therapy for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (SFA) and/or Proximal Popliteal Artery (PPA)
Natural Vascular Scaffolding (NVS) Therapy for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (SFA) and/or Proximal Popliteal Artery (PPA)
Enrollment Status: Completed
Publish Date: July 14, 2022
Intervention Type: Combination product
Study Phase: Phase 1
A Prospective, Multicenter, Single Blind, Randomized, Controlled Trial Comparing the Lutonix Drug Coated Balloon Versus Standard Balloon Angioplasty for Treatment of Below-the-Knee (BTK) Arteries(Lutonix BTK Trial)
A Prospective, Multicenter, Single Blind, Randomized, Controlled Trial Comparing the Lutonix Drug Coated Balloon Versus Standard Balloon Angioplasty for Treatment of Below-the-Knee (BTK) Arteries(Lutonix BTK Trial)
Enrollment Status: Completed
Publish Date: February 09, 2022
Intervention Type: Device
Study Phase: Not Applicable
Multi-center, Prospective, PM Registry for Procedural Outcomes Using the Cardiva VASCADE VCS for Closing the Femoral Arteriotomy After Percutaneous Endovascular Procedures Via Antegrade Access.
Multi-center, Prospective, PM Registry for Procedural Outcomes Using the Cardiva VASCADE VCS for Closing the Femoral Arteriotomy After Percutaneous Endovascular Procedures Via Antegrade Access.
Enrollment Status: Completed
Publish Date: January 18, 2020
Intervention Type: Device
The COPPER-A Trial: The Occlusion Perfusion Catheter for Optimal Delivery of Paclitaxel for the Prevention of Endovascular Restenosis - Above and Below the Knee
The COPPER-A Trial: The Occlusion Perfusion Catheter for Optimal Delivery of Paclitaxel for the Prevention of Endovascular Restenosis - Above and Below the Knee
Enrollment Status: Completed
Publish Date: November 08, 2019
Intervention Type: Other
Study Phase: Not Applicable
A Double-Blind, Placebo-Controlled, Randomized, Parallel Assignment, U.S. Study of Ranolazine for the Treatment of Patients With Diabetic Peripheral Neuropathic Pain (DPNP)
A Double-Blind, Placebo-Controlled, Randomized, Parallel Assignment, U.S. Study of Ranolazine for the Treatment of Patients With Diabetic Peripheral Neuropathic Pain (DPNP)
Enrollment Status: Terminated
Publish Date: February 10, 2017
Intervention Type: Drug
Study Phase: Phase 4
View 11 Less Clinical Trials

13 Total Publications

Surgery or Endovascular Therapy for Chronic Limb Ischemia.
Surgery or Endovascular Therapy for Chronic Limb Ischemia.
Journal: The New England journal of medicine
Published: March 15, 2023
Similar Doctors
Experienced in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
Dr. Emmett B. Chapital
Cardiology | Nuclear Medicine
Experienced in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
Dr. Emmett B. Chapital
Cardiology | Nuclear Medicine
1221 N Braod St, 
New Orleans, LA 
 (45.6 miles away)
504-482-9755
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Emmett Chapital is a Cardiologist and a Nuclear Medicine provider in New Orleans, Louisiana. Dr. Chapital is rated as an Advanced provider by MediFind in the treatment of Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy. His top areas of expertise are Glucocorticoid-Remediable Aldosteronism, Hypertension, Mitral Valve Prolapse, and Vitamin D Deficiency. Dr. Chapital is currently accepting new patients.

Experienced in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
Dr. Kenneth E. Wong
Cardiology
Experienced in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
Dr. Kenneth E. Wong
Cardiology

Cardiovascular Institute

102 Twin Oaks Drive, 
Raceland, LA 
 (11.4 miles away)
985-537-4000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Kenneth Wong is a Cardiologist in Raceland, Louisiana. Dr. Wong is rated as a Distinguished provider by MediFind in the treatment of Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy. His top areas of expertise are Hypertensive Heart Disease, Pediatric Myocarditis, Necrosis, Heart Bypass Surgery, and Pacemaker Implantation. Dr. Wong is currently accepting new patients.

Experienced in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
Dr. William R. Ladd
Cardiology
Experienced in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
Dr. William R. Ladd
Cardiology

Cardiovascular Institute

225 Dunn St, 
Houma, LA 
 (0.1 miles away)
985-876-0300
Languages Spoken:
English
See accepted insurances
Accepting New Patients

William Ladd is a Cardiologist in Houma, Louisiana. Dr. Ladd is rated as a Distinguished provider by MediFind in the treatment of Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy. His top areas of expertise are Hypertensive Heart Disease, Angina, Pediatric Myocarditis, and Hypertension. Dr. Ladd is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Walker's expertise for a condition
ConditionClose
    View All 7 Distinguished Conditions
    View All 15 Advanced Conditions
    View All 60 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile